ASNS promotes alpha-aminobutyric acid secretion, thereby augmenting the expression of MHC and antigen-presentation genes in lung cancer cells, and consequently enhancing the cytotoxicity of CD8+T cells. The gene discussed is CD8A; the disease is lung carcinoma.